Terumo Corporation, founded in 1921 and headquartered in Tokyo, Japan, is a prominent global medical technology company committed to advancing healthcare through innovative solutions. The company specializes in the development and manufacturing of medical devices, pharmaceuticals, and blood management systems, featuring products like transfusion and IV therapy equipment.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| TERUMO 4.49% 2031-04-28 USDTerumo Corporation | Japan | 2031-04-28 | 4.488 | 5.03 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Terumo started issuing bonds in the late 1990s as part of its strategy to finance expansion and R&D initiatives. Notably, in 2021, the company raised ¥30 billion through a bond issuance to support its growth in emerging markets, offering yields competitive with industry averages. Recent bond offerings included green bonds aimed at financing eco-friendly initiatives, reflecting a focus on sustainability. With current yields in line with corporate bond standards, Terumo's debt instruments remain a vital component of its financial strategy.